Get the Stockscreener App
6.18
6.93%
-0.46
After Hours:
6.18
Aura Biosciences Inc stock is traded at $6.18, with a volume of 193.95K.
It is down -6.93% in the last 24 hours and down -10.95% over the past month.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
See More
Previous Close:
$6.64
Open:
$6.67
24h Volume:
193.95K
Relative Volume:
1.07
Market Cap:
$383.90M
Revenue:
-
Net Income/Loss:
$-76.41M
P/E Ratio:
-3.2188
EPS:
-1.92
Net Cash Flow:
$-64.56M
1W Performance:
-4.63%
1M Performance:
-10.95%
6M Performance:
-17.49%
1Y Performance:
-36.87%
1-Day Range:
$6.17
$6.721
1-Week Range:
$6.17
$6.721
52-Week Range:
$4.345
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
Name
Aura Biosciences Inc
Sector
Industry
Phone
(617)500-8864
Address
80 GUEST STREET, BOSTON
Compare AURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
6.18 | 400.05M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Resumed | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | H.C. Wainwright | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Jul-19-22 | Initiated | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Stock (AURA) Latest News
Is Aura Biosciences Inc. stock entering bullish territoryTrade Ideas & Verified Technical Signals - Newser
Institutional scanner results for Aura Biosciences Inc.July 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Sentiment analysis tools applied to Aura Biosciences Inc.2025 Earnings Surprises & Community Consensus Trade Alerts - Newser
Aura Biosciences Inc. stock prediction for this weekWeekly Risk Summary & Precise Trade Entry Recommendations - Newser
Will Aura Biosciences Inc. see short term momentumMarket Weekly Review & Daily Stock Trend Watchlist - Newser
Key metrics from Aura Biosciences Inc.’s quarterly dataJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Will Aura Biosciences Inc. bounce back from current supportBuy Signal & Community Verified Trade Alerts - Newser
Can machine learning forecast Aura Biosciences Inc. recoveryJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
Real time scanner hits for Aura Biosciences Inc. explainedTrade Exit Summary & Technical Pattern Based Buy Signals - Newser
Will Aura Biosciences Inc. continue its uptrend2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
Can Aura Biosciences Inc. hit a new high this monthEarnings Performance Report & Weekly Momentum Stock Picks - Newser
Momentum divergence signals in Aura Biosciences Inc. chartOil Prices & Verified Swing Trading Watchlist - Newser
Is it too late to sell Aura Biosciences Inc.Weekly Trend Summary & Technical Entry and Exit Tips - Newser
Backtesting results for Aura Biosciences Inc. trading strategiesWeekly Earnings Recap & Low Risk High Win Rate Stock Picks - Newser
Forecasting Aura Biosciences Inc. price range with options dataJuly 2025 Pullbacks & Stock Timing and Entry Methods - Newser
Analyzing Aura Biosciences Inc. with risk reward ratio charts2025 Stock Rankings & Consistent Profit Alerts - Newser
Analysts Set Aura Biosciences, Inc. (NASDAQ:AURA) Price Target at $22.00 - Defense World
What institutional flow reveals about Aura Biosciences Inc.Stop Loss & Weekly Top Stock Performers List - Newser
Analyzing recovery setups for Aura Biosciences Inc. investorsDollar Strength & AI Enhanced Trading Alerts - Newser
Aura Biosciences Inc. stock daily chart insightsChart Signals & High Win Rate Trade Alerts - Newser
aura biosciences inc. stock prediction for this weekJuly 2025 News Drivers & Reliable Volume Spike Alerts - Newser
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Will breakout in Aura Biosciences Inc. lead to full recoveryEarnings Growth Report & Safe Entry Zone Identification - Newser
Can volume confirm reversal in Aura Biosciences Inc.2025 Analyst Calls & Growth Oriented Trading Recommendations - Newser
Tools to monitor Aura Biosciences Inc. recovery probability2025 Winners & Losers & Low Risk Entry Point Guides - Newser
Short Term Trend Reversal in Aura Biosciences Inc. Possible2025 Price Targets & Daily Stock Trend Watchlist - beatles.ru
Aura Biosciences Inc. Flashes Rebound Signal in Oversold ConditionTrade Performance Summary & AI Driven Price Predictions - beatles.ru
How to monitor Aura Biosciences Inc. with trend dashboardsWeekly Profit Analysis & Reliable Volume Spike Alerts - Newser
What the charts say about Aura Biosciences Inc. today2025 Trading Volume Trends & Long-Term Growth Stock Strategies - Newser
Aura Biosciences Inc Stock (AURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):